NOVARTINDPharmaceuticals
Novartis India Ltd — PE Ratio & Valuation Analysis
₹672.25
+0.00%
Current P/E18.79xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E53.9x65.1% below avg
✅
40.9% Discount to Industry
NOVARTIND P/E 18.79x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2023 | ₹41.86 | ₹672 | 16.1x |
| 2021 | ₹8.46 | ₹776 | 91.7x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Novartis India Ltd Valuation
Novartis India Ltd (NOVARTIND) currently trades at 18.79x earnings. The Pharmaceuticals sector average PE is 31.77x. NOVARTIND is trading at a discount to peers — may indicate relative value. Historically, NOVARTIND has traded at an average PE of 53.9x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
13.18%
Dividend Yield
3.08%
More on Novartis India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.